Infection with feline immunodeficiency virus (FIV) leads to the development of a disease state similar to AIDS in man. Recent studies have identified the chemokine receptor CXCR4 as the major receptor for cell culture-adapted strains of FIV, suggesting that FIV and human immunodeficiency virus (HIV) share a common mechanism of infection involving an interaction between the virus and a member of the seven transmembrane domain superfamily of molecules. In this article, we review the evidence for the involvement of chemokine receptors in FIV infection and contrast these findings with similar studies on the primate lentiviruses HIV and SIV (simian immunodeficiency virus).
Introduction
Feline immunodeficiency virus (FIV) is a widespread pathogen of the domestic cat, infection resulting in an immune dysfunction characterised by a progressive depletion of CD4+ lymphocytes from the peripheral blood (Ackley et al. 1990 ; Novotney et al. 1990 ). Lentiviruses have also been identified in non-domestic felids such as the Pallas cat (Barr et al. 1997) , pumas (Langley et al. 1994 ) and lions 2 (Brown et al. 1994) . Phylogenetic analyses have demonstrated that the lion and puma lentiviruses (LLV and PLV respectively) are more closely related to FIV than to either the primate or the ungulate lentiviruses. However, whether PLV or LLV induce an immunodeficiency in their natural host is unclear; in many cases infection may be inapparent as has been observed with SIV SM infection in the sootey mangabey. Indeed, amino acid sequence comparisons between the envelope glycoproteins of FIV and PLV-14 revealed only 8% similarity (37% nucleic acid similarity) (Langley et al. 1994) suggesting an ancient divergence between FIV and PLV.
FIV infects a range of CD4-negative cell types including monocyte/macrophages (Brunner and Pedersen, 1989) , B cells (Dean et al. 1996; English et al. 1993 ) and cells of neuronal lineage (Dow et al. 1990) , and CD4 expression in vitro does not correlate with susceptibility to infection with FIV (Willett et al. 1991) . Indeed, CD4 expression in the cat is restricted to T-helper lymphocytes and their thymic precursors and unlike in human beings it is not expressed on monocytes and macrophages. While the principal in vivo target of FIV during early infection appears to be the CD4 + T cell, with increased time post-infection the major reservoir for proviral DNA appears to be CD21 + lymphocytes (B-cells) and CD8 + Tcells (Dean et al. 1996; English et al. 1993) . Whether B-cells are productively infected with FIV, or whether viral uptake occurs via a complement-dependent mechanism as described for HIV (Boyer et al. 1991; Robinson et al. 1990 ) has yet to be ascertained, however, these studies provide compelling evidence for the existence of a non-CD4 receptor for FIV.
Indeed, ectopic expression of feline CD4 on feline cell lines of non-lymphoid origin does not render the cells permissive for infection with lymphotropic isolates of FIV (Norimine et al. 1993 (Olmsted et al. 1989 ) and 34TF10 (Talbott et al. 1989) were derived from infected CrFK cells. These "CrFK-adapted" strains of FIV have an expanded cell tropism which permits infection of a wide range of feline cell lines. Furthermore, several non-feline cell lines, such as the canine cell line MDCK and the human cell line HeLa (Egberink et al. 1991) , are susceptible to infection with CrFK-adapted strains of FIV. Originally, it was thought that the mechanism underlying this expanded cell tropism of FIV was pseudotypic mixing between FIV and the feline endogenous retrovirus RD114 (Egberink et al. 1991) , a retrovirus produced in large quantities by many feline cell lines including CrFK. While pseudotypic mixing between FIV and RD114 has not been excluded, subsequent studies have demonstrated that transfection of human cells with plasmid vectors expressing the FIV envelope glycoprotein gene (env) from a CrFK-adapted strain of FIV resulted in syncytium formation (Pancino et al. 1995) , suggesting that the viral envelope glycoprotein (Env) determines the expanded cell tropism of these types of virus. In agreement with these findings, the critical determinant of CrFK-tropism was localised to the third variable region (V3 loop) of the Env protein. Two independent studies demonstrated that an increase in the net charge of the V3 loop was sufficient to render 4 some primary isolates of FIV "CrFK-tropic" (Siebelink et al. 1995; Verschoor et al. 1995) . The increase in charge resulted from the mutation of either of two glutamate residues (407 and 409) in the V3 loop to lysine residues (Figure1). These studies mirrored observations made with HIV regarding the switch from an NSI (nonsyncytium inducing) to an SI (syncytium inducing) phenotype (de Jong et al. 1992) and suggested that CrFK-adapted strains of FIV and SI strains of HIV shared a common mechanism of infection.
Identification of CXCR4 as a receptor for FIV
The identification of the orphan seven transmembrane domain receptor LESTR (lymphocyte expressed seven transmembrane domain receptor, subsequently re-named CXCR4 -the receptor for the α-chemokine SDF-1) as the principal cofactor for CD4-dependent infection with SI strains of HIV-1 (Feng et al. 1996 ) provided a molecular basis for the adaptation of HIV to grow in T cell lines; primary isolates of HIV were not able to use CXCR4 as a cofactor whereas those selected for growth in established cell lines interacted with CXCR4. CXCR4 was therefore implicated in infection with CrFK-adapted strains of FIV. As the envelope glycoprotein of CrFKadapted strains of FIV is able to induce cell-cell fusion in human cell lines (Pancino et al. 1995) , the role of CXCR4 in FIV infection could be addressed directly by examining the ability of the anti-CXCR4 antibody 12G5 to inhibit fusion between FIV-infected CrFK cells and the human cell line HeLa. Incubation of the cells in the presence of the antibody 12G5 resulted in a dose-dependent inhibition of syncytium formation . In contrast, cell fusion was not inhibited by incubation with either antibody recognising feline CD9 or a polyclonal goat serum raised against the envelope glycoprotein of the feline endogenous retrovirus RD114. However, cell rendered these cells permissive for fusion with FIV-infected CrFK cells .
In order to demonstrate that FIV interacts directly with CXCR4, binding studies were performed using 125 I-labelled SDF-1α and a derivative of the human cell line U87 transfected stably with feCXCR4 (Hosie et al. 1998) . However, the HIV-1 IIIb gp120 binding studies were performed with CD4-negative human neurones and infection with HIV-1 IIIB is CD4-dependent; this may account for the lower affinity interaction between the IIIB gp120 and CXCR4. As yet, binding of envelope glycoprotein from CD4-independent strains of HIV to CXCR4 has not been examined but studies on the binding of envelope glycoproteins to the β-chemokine receptor CCR5 in the presence of CD4 have demonstrated half-maximal inhibition of 125 I-labelled MIP-1α (a CCR5 ligand) at concentrations from approximately 1 to 5nM (Hill et al. 1997; Wu et al. 1996) . Also, SIVmac239 gp120
binds rhesus macaque CCR5 in the absence of CD4 with a K D of 14.36+3.90nM (Martin et al. 1997) . Therefore it appears that there is indeed a high affinity interaction between FIV gp120 and CXCR4, implicating CXCR4 itself as the primary receptor for CrFK-adapted strains of FIV. Our recent studies have demonstrated that transfection of murine or hamster cell lines with CXCR4 renders the cells permissive for fusion with FIV-infected CrFK cells (Willett et al. 1998) suggesting that either a highly conserved component of the feline, murine and hamster cell surface acts as the primary viral receptor or infection is mediated by CXCR4 alone, analogous to infection with CD4-independent strains of HIV-2. In agreement with these findings, recent studies by Poeschla and Looney (Poeschla and Looney, 1998) have demonstrated that replication-defective FIV pseudotypes based on the 34TF10 molecular clone of FIV will infect human cells in the presence, but not in the absence, of human CXCR4. Furthermore, the post-entry block to FIV infection that exists in human cells (Ikeda et al. 1996) would appear to be due to poor promoter activity of the FIV LTR U3 element (Poeschla and Looney, 1998) as when a heterologous promoter is substituted, efficient production of infectious FIV occurs.
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Inhibition of FIV infection by CXCR4 antagonists
The natural ligand for CXCR4 has been identified as the chemokine SDF-1 (stromal cell derived factor) (Bleul et al. 1996; Oberlin et al. 1996 ). As we had CrFK cells with SDF-1 led to enhanced expression of CXCR4 and increased susceptibility to FIV infection (Hosie et al. 1998) . Recent studies have suggested that SDF-1 has broad anti-viral activity against FIV and that the inhibition of infection extends not only to other antigenically distinct subtype A isolates, but also to isolates from subtype B and D (Endo et al. 1998) . Importantly, SDF-1 did not inhibit infection of the T-lymphoblastoid cell line Mya-1 with FIV PET (Hosie et al. 1998) ,
suggesting the existence of a CXCR4-independent pathway of infection with FIV.
However, Endo et al have observed inhibition of FIV infection by SDF-1β in the lymphoid cell line Kumi-1 (Endo et al. 1998) and Egberink et al demonstrated that
infection of thymocytes with FIV UT113 is inhibited by the CXCR4 antagonist AMD3100 (Egberink et al. 1998) . The studies by Endo et al and Egberink et al. are significant in that they suggest a role for CXCR4 in infection with primary strains of FIV. It is conceivable that the restricted tropism of primary isolates may the reflect a 8 requirement for expression of a high affinity primary receptor in conjunction with CXCR4 for infection to occur, analogous to the use of CD4 as a primary receptor by HIV, and that cell culture adaptation allows the virus to infect using CXCR4 alone. A precedent for this model has already been set with the discovery that CD4-independent strains of HIV-2 use CXCR4 as the sole receptor for infection (Endres et al., 1996) . Future studies should therefore address the mechanism of FIV infection of inhibited FIV infection were similar to those inhibiting HIV-1 infection (Donzella et al. 1998; Doranz et al. 1997) , again suggesting that FIV and HIV interact in a similar way with CXCR4 to promote infection.
Mapping of domains on CXCR4 involved in FIV infection
The discovery that FIV interacts specifically with the chemokine receptor CXCR4 suggests that despite the evolutionary divergence of FIV and HIV, the envelope glycoproteins of FIV and HIV share conserved structural features enabling a 9 high affinity interaction. Several studies have demonstrated that the alterations in the V3 loop that generate an SI phenotype select for usage of CXCR4 as a coreceptor Speck et al. 1997) , suggesting that the V3 loop contributes to the CXCR4 binding site. Given that mutations in the V3 loop of FIV select for CrFK adaptation and usage of CXCR4 as a receptor, the data suggest that the CXCR4 binding sites of both viruses are structurally similar and that the V3 loop contributes to the structure. The interaction between HIV and CXCR4 has been investigated using a series of chimaeric CXCR4 molecules generated between CXCR4 and the related α-chemokine receptor CXCR2. These studies demonstrated that the first and second extracellular loops of CXCR4 were found to be important determinants of the interaction with CD4-dependent T-tropic or dual-tropic strains of HIV (Lu et al. 1997 ). In contrast, M-tropic strains could only use CXCR4 when the amino terminus was substituted with that of CCR5 (Lu et al. 1997) . Similarly, when chimaeras were generated between human CXCR4 and the rat homologue of CXCR4, the second extracellular loop was found to be the principal determinant of CXCR4-usage by the NDK strain of HIV-1 (Brelot et al. 1997) . In agreement with these findings, chimaeras constructed between murine and human CXCR4 have demonstrated that the second loop of human CXCR4 expressed in the context of murine CXCR4 renders canine thymocytes susceptible to infection with HIV-1 strains that are unable to use murine CXCR4 as a receptor (Parolin et al. 1998) .
In recent studies, we have investigated the interaction between FIV and CXCR4 using the panels of chimaeric CXCR4 molecules described above. Using rat CXCR4/human CXCR4 chimaeras (Brelot et al. 1997 ) the principal determinant of CXCR4 usage by FIV was localised to the second extracellular loop; a chimaeric molecule derived almost entirely from rat CXCR4, except for the second extracellular 10 loop which was derived from human CXCR4, supported both fusion and infection with similar efficiency to the parent human CXCR4 molecule (Willett et al. 1998) .
When similar studies were performed using human CXCR2/human CXCR4 chimaeras, substitution of the first or third extracellular domains of CXCR4 with the corresponding domains of CXCR2 rendered the molecule non-functional as an FIV receptor. The data suggest that either the first and third extracellular loops of CXCR4 contribute to the FIV Env binding site or that these domains are required to present the second extracellular loop in the appropriate conformation for the interaction with the FIV Env. Previous studies have suggested that the N-terminal extracellular domain of CXCR4 is required for CXCR4 to function as a coreceptor for some strains of HIV (Lu et al. 1997) . However, mutant CXCR4 molecules in which the N-terminus was either replaced with the corresponding domain of CXCR2, or was removed completely to form a truncated molecule, supported both fusion and infection with
CrFK-adapted FIV (Willett et al. 1998) , suggesting that this portion of the molecule is not required for the interaction with FIV Env.
Conclusions
Adaptation of FIV to replicate in the CrFK cell line is accompanied by the selection of viruses that are capable of interacting with the chemokine receptor CXCR4. These CXCR4-dependent strains of FIV may be analogous to CD4-independent strains of HIV-2 that appear to interact directly with CXCR4 (Endres et al. 1996) . Indeed, it has been demonstrated recently that the second extracellular loop of CXCR4 is the principal determinant of CXCR4 usage by HIV-2 ROD/B (Reeves et al. 1998) . There are a number of striking similarities between CrFK-adapted strains of FIV and HIV-2 ROD/B. Adaptation of FIV to a CrFK-tropic phenotype is 11 accompanied by a glutamate to lysine switch in the V3 loop of the virus, increasing the net charge of the V3 loop. Also, a similar mutation in the V3 loop of HIV-2 ROD-B (mutation of glutamine 310 to lysine) enhances the CD4-independent phenotype(Reeves and Schultz, 1997) of the virus. Furthermore, while a methionine 751 to threonine mutation in the TM protein of FIV is associated with the CrFKtropic phenotype (Vahlenkamp et al. 1997 ), a similar alanine 526 to threonine mutation in the TM protein of HIV-2 ROD is observed upon adaptation to a CD4-independent phenotype (Reeves and Schultz, 1997) , in each case the mutations are located adjacent to the region of TM thought to be involved in the formation of a coiled-coil domain involved in oligomerization, viral entry and neutralization (Cao et al. 1993; Dubay et al. 1992; Ho et al. 1987; Muster et al. 1993; Wild et al. 1993 ).
Although mutations in other regions of the env gene are thought to be necessary to confer a CrFK-tropic phenotype on FIV (Siebelink et al. 1995; Vahlenkamp et al. 1997; Verschoor et al. 1995) , and a CD4-independent phenotype on HIV-2 (Reeves and Schultz, 1997), both viruses adapt in a similar way to the use of pathways for infection that result ultimately in the use of CXCR4 alone as a viral receptor. These studies suggest that common structural motifs remain despite the divergence in amino acid sequence between FIV and HIV. By comparing the mechanism of infection with the feline and human lentiviruses, it may be possible to define the regions of the Env protein that are essential for the chemokine receptor interaction and ultimately to design novel therapeutic agents that can be used in the treatment of lentiviral diseases. loop. E to K mutations are present in the 34TF10 (Talbott et al. 1989 ), F14 (Olmsted et al. 1989 ), UT113Cr (Verschoor et al. 1995) and 19K1PBAM6 (Siebelink et al. 1995) strains of FIV, all of which have been selected for growth in CrFK cells. 
